Treatment options for pancreatic neuroendocrine tumors (PNETs) have expanded considerably based on data from pivotal trials ...
(RTTNews) - Ipsen (IPSEY) announced confirmation of an expanded collaboration and license agreement with Exelixis for the development of Cabometyx (cabozantinib) in advanced pancreatic neuroendocrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results